Immune cell shifts track hepatitis B treatment response
A study of 27 chronic hepatitis B patients found that those achieving HBsAg loss on pegylated interferon-alpha and nucleos(t)ide analog ...
Tag: CD56bright
POPULAR NEWS
-
Systematic review maps end-of-life psychosocial and spiritual needs in physical disability
-
Text Message Campaign Reached Only a Third of Patients Overdue for Colorectal Cancer Screening
-
FOXO1 Emerges as Candidate Regulator and Biomarker in Hip Dysplasia
-
Regulators, developers and clinicians in Shenzhen voice concerns over medical AI governance